- Report
- June 2026
- 330 Pages
Global
From €4460EUR$4,950USD£3,827GBP
- Report
- January 2026
- 198 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- January 2026
- 192 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- January 2026
- 189 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- November 2025
- 307 Pages
Global
From €4055EUR$4,500USD£3,479GBP
- Report
- September 2026
- 196 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 193 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 186 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 180 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 187 Pages
Global
From €3194EUR$3,545USD£2,740GBP
€3549EUR$3,939USD£3,045GBP
- Report
- September 2026
- 197 Pages
Global
From €3194EUR$3,545USD£2,741GBP
€3549EUR$3,939USD£3,045GBP
- Report
- April 2026
- 148 Pages
Global
From €2702EUR$2,999USD£2,318GBP
€3603EUR$3,999USD£3,091GBP
- Report
- April 2026
Global
From €4415EUR$4,900USD£3,788GBP
- Report
- September 2026
- 174 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 104 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 370 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 197 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 226 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 183 Pages
Global
From €5271EUR$5,850USD£4,522GBP
- Report
- September 2026
- 482 Pages
Global
From €5271EUR$5,850USD£4,522GBP

The Immunoglobulin market is a segment of the Immune Disorders Drugs market, which focuses on treatments for conditions related to the immune system. Immunoglobulin (Ig) is a type of protein found in the blood that helps fight infection and disease. It is used to treat a variety of immune-related conditions, including autoimmune diseases, allergies, and infections. Immunoglobulin therapies are typically administered intravenously or subcutaneously, and can be used to replace or supplement the body's natural Ig production.
The Immunoglobulin market is highly competitive, with a number of companies offering a range of products. These products vary in terms of dosage, delivery method, and cost. Companies in the market are focused on developing new therapies and improving existing ones, as well as expanding their product portfolios.
Some of the major companies in the Immunoglobulin market include CSL Behring, Grifols, Kedrion, Octapharma, and Shire. Show Less Read more